Clinical trial
The Janus Rectal Cancer Trial: A Randomized Phase II/III Trial Testing the Efficacy of Triplet Versus Doublet Chemotherapy Regarding Clinical Complete Response and Disease-free Survival in Patients With Locally Advanced Rectal Cancer
NCT05610163 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Janus Rectal Cancer Trial: A Randomized Phase II/III Trial Testing the Efficacy of Triplet Versus Doublet Chemotherapy Regarding Clinical Complete Response and Disease-free Survival in Patients With Locally Advanced Rectal Cancer
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Phase
- Phase 2/3
- Overall status
- Active, not recruiting
- Start date
- December 8, 2022
- Completion date
- July 1, 2037
- Enrollment
- 760 (actual)
- Sites
- 685
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced rectal adenocarcinoma, stage ii rectal cancer ajcc v8, stage iii rectal cancer ajcc v8